2859 A multicenter phase II of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullar thyroid carcinoma: Mature data of THYSU study. (September 2015) - De La Fouchardiere, C.; Delord, J.P.; Bazignan, A. Doussau De; Catargi, B.; Docao, C.; Asselineau, J.; Picat, M.Q.; Rodien, P.; Pouessel, D.; Nicolli-Sire, P.; Klein, M.; Bournaud-Salinas, C.; et al.